Merck’s health business gains new Global Head of R&D
By Dominic Tyer (European Pharmaceutical Review)
Critical Medicines Act ‘must prioritise’ EU pharmaceutical manufacturing competitiveness
By Catherine Eckford (European Pharmaceutical Review)
Understanding European regulatory requirements for low-GWP propellant transition
By Catherine Eckford (European Pharmaceutical Review)
CSL to slash headcount by 15% and spinout its CSL Seqirus vaccines business
By Dominic Tyer (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)